Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.

about

Ghrelin, Amylin, Gastric Inhibitory Peptide and Cognition in Middle-Aged HIV-Infected and Uninfected Women: The Women's Interagency HIV Study.Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.

P2860

Q40129940-3A4C1BBE-045C-4396-B743-D4C759257E37 Q45399942-EBD78BD6-F513-48AB-9957-D1BC211C2374

P2860

Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.

Item

http://www.wikidata.org/entity/Q46419540

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Enhanced glucagon-like peptide ...... nts on antiretroviral therapy.

@en

Enhanced glucagon-like peptide-1

@nl

type

Item

label

Enhanced glucagon-like peptide ...... nts on antiretroviral therapy.

@en

Enhanced glucagon-like peptide-1

@nl

prefLabel

Enhanced glucagon-like peptide ...... nts on antiretroviral therapy.

@en

Enhanced glucagon-like peptide-1

@nl

P1476

Enhanced glucagon-like peptide ...... nts on antiretroviral therapy.

@en

P2093

Andersen UB

http://www.w3.org/2001/XMLSchema#string

Deacon CF

http://www.w3.org/2001/XMLSchema#string

Haugaard SB

http://www.w3.org/2001/XMLSchema#string

Iversen J

http://www.w3.org/2001/XMLSchema#string

Nielsen JO

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic effects of indinavir in healthy HIV-seronegative men

Disorders of glucose metabolism in patients infected with human immunodeficiency virus.

Insulin resistance in the HIV-lipodystrophy syndrome.

Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.

Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.

Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.

Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling.

Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function.

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.

The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

P304

91-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-1293.2005.00270.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jens Juul Holst

Sten Madsbad

Ove Andersen

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15807714

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.

about

P2860

P2860

Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921